Design, synthesis and cholinesterase inhibitory evaluation study of fluorescent N-benzylpiperidine-4-one derivatives

被引:4
作者
Sukumarapillai, Dileep Kumar [1 ]
Kooi-Yeong, Khaw [2 ]
Kia, Yalda [2 ]
Murugaiyah, Vikneswaran [2 ]
Iyer, Sathiyanarayanan Kulathu [1 ]
机构
[1] Vellore Inst Technol Univ, Sch Adv Sci, Vellore 632014, Tamil Nadu, India
[2] Univ Sains Malaysia, Discipline Pharmacol, Sch Pharmaceut Sci, George Town 11800, Malaysia
关键词
N-benzylpiperidin-4-one; Alzheimer's disease; Cholinesterase; Enzyme kinetics; Molecular docking; Fluorescence; ALZHEIMERS-DISEASE; BUTYRYLCHOLINESTERASE INHIBITORS; MOLECULAR DOCKING; BINDING-SITE; ACETYLCHOLINESTERASE; POTENT;
D O I
10.1007/s00044-016-1619-6
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Some N-benzylpiperidine-4-one derivatives were synthesized via one-pot three-component protocols in excellent yields, and were evaluated for their potential cholinesterase inhibition. The mono-substituted derivatives except 4b showed butyrylcholinesterase selective, while unsubstituted and di-substituted derivatives showed acetylcholinesterase selective inhibitions. It is interesting to note that all the mono-substituted derivatives showing butyrylcholinesterase inhibitory activity were more potent than galanthamine. Compound 4c bearing ortho-methoxy group showed the most potent, mixed-mode inhibitory activity on both acetylcholinesterase and butyrylcholinesterase with IC50 5.67 and 0.87 mu M, respectively. Molecular docking revealed that compound 4c had hydrophobic interactions and hydrogen bonding at the catalytic triad and choline binding sites of the enzymes. In conclusion, this simple and cheaper synthesis method yielded derivatives with good cholinesterase inhibition and favorable photophysical properties.
引用
收藏
页码:1705 / 1715
页数:11
相关论文
共 36 条
[31]   Synthesis and antidepressant activity of some 1,3,5-triphenyl-2-pyrazolines and 3-(2"-hydroxy naphthalen-1"-yl)-1,5-diphenyl-2-pyrazolines [J].
Prasad, YR ;
Rao, AL ;
Prasoona, L ;
Murali, K ;
Kumar, PR .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (22) :5030-5034
[32]   MECHANISMS OF DISEASE Alzheimer's Disease [J].
Querfurth, Henry W. ;
LaFerla, Frank M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (04) :329-344
[33]   Acetylcholinesterase inhibitors: novel activities of old molecules [J].
Racchi, M ;
Mazzucchelli, M ;
Porrello, E ;
Lanni, C ;
Govoni, S .
PHARMACOLOGICAL RESEARCH, 2004, 50 (04) :441-451
[34]   Acetylcholinesterase inhibitors for Alzheimer's disease: anti-inflammatories in acetylcholine clothing! [J].
Tabet, N. .
AGE AND AGEING, 2006, 35 (04) :336-338
[35]   The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: Recent challenges and their implications for novel drug development [J].
Terry, AV ;
Buccafusco, JJ .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 306 (03) :821-827
[36]   Tacrine Derivatives and Alzheimer's Disease [J].
Tumiatti, V. ;
Minarini, A. ;
Bolognesi, M. L. ;
Milelli, A. ;
Rosini, M. ;
Melchiorre, C. .
CURRENT MEDICINAL CHEMISTRY, 2010, 17 (17) :1825-1838